These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31689259)

  • 1. Provision of and Barriers to Integrating Reproductive and Sexual Health Services for Reproductive-age Women in Opioid Treatment Programs.
    Klaman SL; Lorvick J; Jones HE
    J Addict Med; 2019; 13(6):422-429. PubMed ID: 31689259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating Reproductive Health Services Into Opioid Treatment Facilities: A Missed Opportunity to Prevent Opioid-exposed Pregnancies and Improve the Health of Women Who Use Drugs.
    Wright TE
    J Addict Med; 2019; 13(6):420-421. PubMed ID: 31689258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C testing in substance use disorder treatment: the role of program managers in adoption of testing services.
    Frimpong JA; D'Aunno T
    Subst Abuse Treat Prev Policy; 2016 Apr; 11():13. PubMed ID: 27036115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating Reproductive and Sexual Health Education and Services Into Opioid Use Disorder Treatment Programs: A Qualitative Study.
    Klaman SL; Turner K; Lorvick J; Jones HE
    J Addict Med; 2020; 14(5):e175-e182. PubMed ID: 32271200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral Hepatitis and Human Immunodeficiency Virus Testing and Linkage to Care for Individuals Enrolled in an Opioid Treatment Program.
    Rowan SE; Kamis KF; Beum R; Bryan K; Gawenus L; Colon Sanchez D; Hurley H
    J Infect Dis; 2020 Sep; 222(Suppl 5):S384-S391. PubMed ID: 32877565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Need, demand and missed opportunities for integrated reproductive health-HIV care in Kenya and Swaziland: evidence from household surveys.
    Mak J; Birdthistle I; Church K; Friend-Du Preez N; Kivunaga J; Kikuvi J; Masuku R; ; Mayhew SH
    AIDS; 2013 Oct; 27 Suppl 1():S55-63. PubMed ID: 24088685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing integrated community-based HIV prevention, harm reduction, and sexual and reproductive health services for women who inject drugs.
    Ayon S; Jeneby F; Hamid F; Badhrus A; Abdulrahman T; Mburu G
    Reprod Health; 2019 May; 16(Suppl 1):59. PubMed ID: 31138238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics and current clinical practices of opioid treatment programs in the United States.
    Jones CM; Byrd DJ; Clarke TJ; Campbell TB; Ohuoha C; McCance-Katz EF
    Drug Alcohol Depend; 2019 Dec; 205():107616. PubMed ID: 31678836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outpatient drug treatment program directors' hepatitis C-related beliefs and their relationship to the provision of HCV services.
    Astone JM; Strauss SM; Hagan H; Des Jarlais DC
    Am J Drug Alcohol Abuse; 2004 Nov; 30(4):783-97. PubMed ID: 15624549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Women's costs for accessing comprehensive sexual and reproductive health services: findings from an observational study in Johannesburg, South Africa.
    Lince-Deroche N; Berry KM; Hendrickson C; Sineke T; Kgowedi S; Mulongo M
    Reprod Health; 2019 Dec; 16(1):179. PubMed ID: 31842904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of viral hepatitis services into opioid treatment programs.
    Kresina TF; Bruce RD; Lubran R; Clark HW
    J Opioid Manag; 2008; 4(6):369-81. PubMed ID: 19192765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with pregnant adolescents' access to sexual and reproductive health services in New York City.
    Flanagan KF; Cunningham SD; Lewis JB; Tobin JN; Ickovics JR
    Sex Reprod Healthc; 2019 Mar; 19():50-55. PubMed ID: 30928135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study protocol for Project I-Test: a cluster randomized controlled trial of a practice coaching intervention to increase HIV testing in substance use treatment programs.
    Frimpong JA; Parish CL; Feaster DJ; Gooden LK; Nelson MC; Matheson T; Siegel K; Haynes L; Linas BP; Assoumou SA; Tross S; Kyle T; Liguori TK; Toussaint O; Annane D; Metsch LR
    Trials; 2023 Sep; 24(1):609. PubMed ID: 37749635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Care Integration for Hepatitis C Virus Treatment Through Facilitated Telemedicine Within Opioid Treatment Programs: Qualitative Study.
    Dickerson SS; George SJ; Ventuneac A; Dharia A; Talal AH
    J Med Internet Res; 2024 Jun; 26():e53049. PubMed ID: 38865703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sexual and Reproductive Health Characteristics of Women in Substance Use Treatment in Michigan.
    MacAfee LK; Harfmann RF; Cannon LM; Kolenic G; Kusunoki Y; Terplan M; Dalton VK
    Obstet Gynecol; 2020 Feb; 135(2):361-369. PubMed ID: 31923070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating hepatitis, STD, and HIV services into a drug rehabilitation program.
    Gunn RA; Lee MA; Callahan DB; Gonzales P; Murray PJ; Margolis HS
    Am J Prev Med; 2005 Jul; 29(1):27-33. PubMed ID: 15958248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reproductive health in school-based health centers: findings from the 1998-99 census of school-based health centers.
    Santelli JS; Nystrom RJ; Brindis C; Juszczak L; Klein JD; Bearss N; Kaplan DW; Hudson M; Schlitt J
    J Adolesc Health; 2003 Jun; 32(6):443-51. PubMed ID: 12782456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of integration indexes to determine the extent of family planning and child immunization services integration in health facilities in urban areas of Nigeria.
    Sheahan KL; Orgill-Meyer J; Speizer IS; Curtis S; Paul J; Weinberger M; Bennett AV
    Reprod Health; 2021 Feb; 18(1):47. PubMed ID: 33622376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of the availability of hepatitis C testing services in opioid treatment programs: results from a national study.
    Frimpong JA; D'Aunno T; Jiang L
    Am J Public Health; 2014 Jun; 104(6):e75-82. PubMed ID: 24825236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substance use service availability in HIV treatment programs: Data from the global IeDEA consortium, 2014-2015 and 2017.
    Parcesepe AM; Lancaster K; Edelman EJ; DeBoni R; Ross J; Atwoli L; Tlali M; Althoff K; Tine J; Duda SN; Wester CW; Nash D;
    PLoS One; 2020; 15(8):e0237772. PubMed ID: 32853246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.